SCHEMBL3671303

SCHEMBL3671303

Cc1ccc(C(N)=O)c(-c2cc3cnn(-c4c(F)cccc4F)c3n(C)c2=O)c1

nearest known ligand 0.70

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 19/20 0.70
MAPKAPK2 P49137 3/20 0.56
MAPK13 O15264 1/20 0.56
RAF1 P04049 1/20 0.56
PDGFRA P16234 1/20 0.56
MAPK12 P53778 1/20 0.56
KCNH2 Q12809 1/20 0.56
MAPK11 Q15759 1/20 0.56
LCK P06239 2/20 0.45
KIT P10721 2/20 0.45
KDR P35968 2/20 0.45
PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3634954 0.82 MAPK14 (1.00) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3635259 0.82 MAPK14 (0.79) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3673322 0.77 MAPK14 (0.79) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3640728 0.75 MAPK14 (0.79) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3767381 0.75 MAPK14 (0.65) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3762600 0.74 MAPK14 (0.66) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3671305 0.74 MAPK14 (0.60) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3674293 0.73 MAPK14 (0.69) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3767675 0.73 MAPK14 (0.78) MAPK14MAPKAPK2MAPK13RAF1PDGFRA
SCHEMBL3669793 0.73 MAPK14 (0.75) MAPK14MAPKAPK2MAPK13RAF1PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152704-A1 PYRAZOLO-PYRIDINONE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE Amgen, Inc (US) 2010-02-17 EP disclosed
WO-2008137176-A1 PYRAZOLO-PYRIDINONE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE AMGEN INC. (US) 2008-11-13 WO disclosed